From Discovery to First-in-Class: Pioneering an Orphan GPCR for Unmet Medical Needs
- Leveraging advanced computational methods to discover and verify a high-potential orphan GPCR linked to our disease of interest
- Pursuing the project against investor and industry skepticism, supported by strong clinical evidence and a differentiated indication strategy
- Presenting early clinical results from Phase I trial